// App-Quantinova.ai

: Calcineurin Inhibitors, Macrolides, and the Risk of Adverse Drug Events in Kidney Transplant Recipients

Researchers

Presenter

  • RachelH.Jeong

Principal Investigators

  • RobertR.Quinn

  • KristaL.Lentine

  • AnitaLloyd

  • PietroRavani

  • BrendaHemmelgarn

  • BrankoBraam

  • AmitX.Garg

  • KevinC.Wen

  • AnitaWong

  • SitaGourishankar

  • NganLam

Medical Centers

  • University of Alberta Hospital, Edmonton, Alberta, Canada

  • University of Calgary, Calgary, AB, Canada

  • Washington University, St. Louis, Missouri, United States

  • London Health Sciences Center, London, ON, Canada

  • Alberta Health Svcs, Edmonton, AB, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • N/A

Biomarkers

  • Creatinine

Drug/Treatment

  • Biaxin

  • Azithromycin

  • Erythromycin

  • E.E.S. 400 Oral

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved